Merck
MRK
#50
Rank
NZ$506.39 B
Marketcap
NZ$204.82
Share price
-1.05%
Change (1 day)
52.49%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$12.54

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$12.46. an increase over its 2024 EPS that were of NZ$11.52.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025NZ$12.417.71%
2024NZ$11.524308.46%
2023NZ$0.26-97.32%
2022NZ$9.7710.92%
2021NZ$8.8184.68%
2020NZ$4.77-27.2%
2019NZ$6.5563.44%
2018NZ$4.01151.11%
2017NZ$1.60-54.58%
2016NZ$3.5130.21%
2015NZ$2.70-61.99%
2014NZ$7.10180.51%
2013NZ$2.53-31.82%
2012NZ$3.716.62%
2011NZ$3.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.99 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.27-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.39-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.25 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.43 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$5.90-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.42-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.11-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel